Consensus OrthoPediatrics Corp.

Equities

KIDS

US68752L1008

Real-time Estimate Cboe BZX 16:29:37 01/05/2024 BST 5-day change 1st Jan Change
30.15 USD +1.75% Intraday chart for OrthoPediatrics Corp. -3.17% -7.07%

Evolution of the average Target Price on OrthoPediatrics Corp.

Price target over the last 5 years

History of analyst recommendation changes

a7.4X3syhuKcZv4fNhVozGXdT9Q5DncWgLqvTqaUZBZiqo.tDyjpGziMPOPH5F49EfVOlUKtG2NLGuvyAzKIv5r3MmyH6DyWdonzbQL6A~f3b46b0818828cf87e17173e7265803b
Truist Securities Adjusts Price Target on OrthoPediatrics to $32 From $31, Maintains Hold Rating MT
Truist Securities Downgrades OrthoPediatrics to Hold From Buy, Adjusts Price Target to $31 From $39 MT
Truist Securities Adjusts Price Target on OrthoPediatrics to $39 From $35, Maintains Buy Rating MT
Truist Adjusts Price Target on OrthoPediatrics to $35 From $31, Maintains Buy Rating MT
Needham Cuts OrthoPediatrics' Price Target to $37 From $55, Maintains Buy Rating MT
BTIG Lowers Price Target on OrthoPediatrics to $52 From $59, Keeps Buy Rating MT
Needham Raises OrthoPediatrics' Price Target to $55 From $51, Maintains Buy Rating MT
Truist Securities Adjusts Price Target on OrthoPediatrics to $57 From $53, Keeps Buy Rating MT
Truist Securities Raises Price Target on OrthoPediatrics to $56 From $47, Maintains Buy Rating MT
Stifel Adjusts Price Target on OrthoPediatrics to $50 From $52, Maintains Buy Rating MT
Stifel Adjusts OrthoPediatrics' Price Target to $50 From $52, Keeps Buy Rating MT
JMP Securities Adjusts Price Target on OrthoPediatrics to $60 From $70, Keeps Market Outperform Rating MT
Needham Cuts Price Target on OrthoPediatrics to $50 From $59 Due to Peer Multiple Contraction, Lower Revenue Estimates; Buy Rating Kept MT
Truist Securities Lowers OrthoPediatrics Price Target to $52 From $66, Maintains Buy Rating MT
Truist Securities Raises Price Target on OrthoPediatrics to $66 From $51, Keeps Buy Rating MT
BTIG Adjusts OrthoPediatrics' Price Target to $61 from $65, Keeps Buy Rating MT
Stifel Nicolaus Lowers OrthoPediatrics' Price Target to $50 From $57, Maintains Buy Rating MT
Piper Sandler Adjusts OrthoPediatrics' Price Target to $55 From $80, Reiterates Overweight Rating MT
Needham Adjusts Price Target for OrthoPediatrics to $59 From $65, Maintains Buy Rating MT
Needham Lowers Price Target for OrthoPediatrics to $65 From $83, Maintains Buy Rating MT
BTIG Adjusts OrthoPediatrics' Price Target to $68 From $75, Keeps Buy Rating MT
Truist Securities Adjusts OrthoPediatrics' Price Target to $75 From $78, Maintains Buy Rating MT
ORTHOPEDIATRICS : JMP Securities Adjusts OrthoPediatrics' Price Target to $77 From $70, Maintains Outperform Rating MT
ORTHOPEDIATRICS : Needham Adjusts OrthoPediatrics' Price Target to $83 From $77, Maintains Buy Rating MT
ORTHOPEDIATRICS : Needham Raises Price Target for OrthoPediatrics to $83 From $77, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
29.63 USD
Average target price
40 USD
Spread / Average Target
+35.00%
High Price Target
50 USD
Spread / Highest target
+68.75%
Low Price Target
34 USD
Spread / Lowest Target
+14.75%

Consensus detail

Consensus revision (last 18 months)

Analysts covering OrthoPediatrics Corp.

Truist Securities
Needham & Co.
BTIG
Stifel Nicolaus
JMP Securities
Piper Sandler
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
  1. Stock Market
  2. Equities
  3. KIDS Stock
  4. Consensus OrthoPediatrics Corp.